Omeros reported $210.22M in Current Assets for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acelrx Pharmaceuticals ACRX:US $ 42.81M 12.68M
Adma Biologics ADMA:US $ 239.8M 31.07M
Aerie Pharmaceuticals AERI:US $ 316.97M 38.68M
Alnylam Pharmaceuticals ALNY:US $ 2589.68M 218.9M
Biomarin Pharmaceutical BMRN:US $ 2394.02M 119.64M
Cytokinetics CYTK:US $ 623.53M 87.85M
Dynavax Technologies DVAX:US $ 940.52M 32.01M
Gilead Sciences GILD:US $ 12629M 2143M
Heron Therapeutics HRTX:US $ 222.59M 31.83M
Insmed INSM:US $ 756.14M 80.9M
Intercept Pharmaceuticals ICPT:US $ 477.35M 24.94M
Knight Therapeutics Inc GUD:CN C$ 331.01M 26.04M
Macrogenics MGNX:US $ 218.2M 61.36M
Mirati Therapeutics MRTX:US $ 1343.12M 164.87M
Omeros OMER:US $ 210.22M 37.67M
Pacira Pharmaceuticals PCRX:US $ 667.02M 199.03M
Pfizer PFE:US $ 54420M 5273M
Regulus Therapeutics RGLS:US $ 57.93M 7.3M
Sangamo Biosciences SGMO:US $ 340.06M 58.7M
Sarepta Therapeutics SRPT:US $ 2530.95M 73.15M
United Therapeutics UTHR:US $ 2586.6M 263M
Vertex Pharmaceuticals VRTX:US $ 10361.3M 800.7M
Vital Therapies VTL:US $ 115.88M 10.89M
Xoma XOMA:US $ 89.61M 7.36M